Endothelial Erg Regulates Expression of Pulmonary Lymphatic Junctional and Inflammation Genes in Mouse Lungs Impacting Lymphatic Transport.
Adri ChakrabortyAlex KimSalam AlAbdullatifJoshua D CampbellYuriy O AlekseyevUlas KaplanVrinda DambalGiovanni LigrestiMaria TrojanowskaPublished in: Research square (2024)
The ETS transcription factor ERG is a master regulator of endothelial gene specificity and highly enriched in the capillary, vein, and arterial endothelial cells. ERG expression is critical for endothelial barrier function, permeability, and vascular inflammation. A dysfunctional vascular endothelial ERG has been shown to impair lung capillary homeostasis, contributing to pulmonary fibrosis as previously observed in IPF lungs. Our preliminary observations indicate that lymphatic endothelial cells (LEC) in the human IPF lung also lack ERG. To understand the role of ERG in pulmonary LECs, we developed LEC-specific inducible Erg -CKO and Erg -GFP-CKO conditional knockout (CKO) mice under Prox1 promoter. Whole lung microarray analysis, flow cytometry, and qPCR confirmed an inflammatory and pro-lymphvasculogenic predisposition in Erg -CKO lung. FITC-Dextran tracing analysis showed an increased pulmonary interstitial lymphatic fluid transport from the lung to the axial lymph node. Single-cell transcriptomics confirmed that genes associated with cell junction integrity were downregulated in Erg- CKO pre-collector and collector LECs. Integrating Single-cell transcriptomics and CellChatDB helped identify LEC specific communication pathways contributing to pulmonary inflammation, trans-endothelial migration, inflammation, and Endo-MT in Erg -CKO lung. Our findings suggest that downregulation of lymphatic Erg crucially affects LEC function, LEC permeability, pulmonary LEC communication pathways and lymphatic transcriptomics.
Keyphrases
- endothelial cells
- single cell
- lymph node
- transcription factor
- pulmonary hypertension
- oxidative stress
- rna seq
- high glucose
- high throughput
- poor prognosis
- dna methylation
- squamous cell carcinoma
- stem cells
- genome wide
- neoadjuvant chemotherapy
- gene expression
- vascular endothelial growth factor
- cell proliferation
- radiation therapy
- idiopathic pulmonary fibrosis
- type diabetes
- pulmonary fibrosis
- genome wide identification
- anti inflammatory
- structural basis
- rectal cancer